Somatic mosaicism in schizophrenia brains reveals prenatal mutational processes.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
11 Oct 2024
Historique:
medline: 10 10 2024
pubmed: 10 10 2024
entrez: 10 10 2024
Statut: ppublish

Résumé

Germline mutations modulate the risk of developing schizophrenia (SCZ). Much less is known about the role of mosaic somatic mutations in the context of SCZ. Deep (239×) whole-genome sequencing (WGS) of brain neurons from 61 SCZ cases and 25 controls postmortem identified mutations occurring during prenatal neurogenesis. SCZ cases showed increased somatic variants in open chromatin, with increased mosaic CpG transversions (CpG>GpG) and T>G mutations at transcription factor binding sites (TFBSs) overlapping open chromatin, a result not seen in controls. Some of these variants alter gene expression, including SCZ risk genes and genes involved in neurodevelopment. Although these mutational processes can reflect a difference in factors indirectly involved in disease, increased somatic mutations at developmental TFBSs could also potentially contribute to SCZ.

Identifiants

pubmed: 39388546
doi: 10.1126/science.adq1456
doi:

Substances chimiques

Transcription Factors 0
Chromatin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

217-224

Auteurs

Eduardo A Maury (EA)

Division of Genetics and Genomics, Manton Center for Orphan Disease, Boston Children's Hospital, Boston, MA 02115, USA.
Bioinformatics and Integrative Genomics Program and Harvard/MIT MD-PHD Program, Harvard Medical School, Boston, MA 02115, USA.
Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Attila Jones (A)

Department of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Vladimir Seplyarskiy (V)

Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA.
Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Thanh Thanh L Nguyen (TTL)

Department of Genetics, Yale School of Medicine, New Haven, CT 06520, USA.
Department of Psychiatry, Yale School of Medicine, New Haven, CT 06520, USA.

Chaggai Rosenbluh (C)

Department of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Taejong Bae (T)

Department of Quantitative Health Sciences, Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Yifan Wang (Y)

Department of Quantitative Health Sciences, Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Alexej Abyzov (A)

Department of Quantitative Health Sciences, Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Sattar Khoshkhoo (S)

Division of Genetics and Genomics, Manton Center for Orphan Disease, Boston Children's Hospital, Boston, MA 02115, USA.
Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA.

Yasmine Chahine (Y)

Division of Genetics and Genomics, Manton Center for Orphan Disease, Boston Children's Hospital, Boston, MA 02115, USA.
Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Sijing Zhao (S)

Division of Genetics and Genomics, Manton Center for Orphan Disease, Boston Children's Hospital, Boston, MA 02115, USA.

Sanan Venkatesh (S)

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Elise Root (E)

Department of Genetics, Yale School of Medicine, New Haven, CT 06520, USA.

Georgios Voloudakis (G)

Center for Disease Neurogenomics, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Panagiotis Roussos (P)

Center for Disease Neurogenomics, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Peter J Park (PJ)

Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA.

Schahram Akbarian (S)

Department of Psychiatry and Neuroscience, Friedman Brain Institute, Mount Sinai, New York, NY 10029, USA.
Department of Neuroscience, Friedman Brain Institute, Mount Sinai, New York, NY 10029, USA.

Kristen Brennand (K)

Department of Genetics, Yale School of Medicine, New Haven, CT 06520, USA.
Department of Psychiatry, Yale School of Medicine, New Haven, CT 06520, USA.

Steven Reilly (S)

Department of Genetics, Yale School of Medicine, New Haven, CT 06520, USA.

Eunjung A Lee (EA)

Division of Genetics and Genomics, Manton Center for Orphan Disease, Boston Children's Hospital, Boston, MA 02115, USA.
Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Shamil R Sunyaev (SR)

Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, USA.
Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Christopher A Walsh (CA)

Division of Genetics and Genomics, Manton Center for Orphan Disease, Boston Children's Hospital, Boston, MA 02115, USA.
Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Departments of Pediatrics and Neurology, Harvard Medical School, Boston, MA 02115, USA.
Howard Hughes Medical Institute, Boston Children's Hospital, Boston, MA 02115, USA.

Andrew Chess (A)

Department of Cell, Developmental and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Department of Neuroscience, Friedman Brain Institute, Mount Sinai, New York, NY 10029, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH